Grünenthal Receives Breakthrough Therapy Designation From U.S. FDA for Neridronic Acid for the Treatment of CRPS
Neridronic acid is the first investigational medicine to receive Breakthrough Therapy Designation for the treatment of C…
Neridronic acid is the first investigational medicine to receive Breakthrough Therapy Designation for the treatment of C…